rs368428251

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_004104.5(FASN):​c.5062G>A​(p.Ala1688Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,538,900 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000014 ( 0 hom. )

Consequence

FASN
NM_004104.5 missense

Scores

6
9
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.64

Publications

1 publications found
Variant links:
Genes affected
FASN (HGNC:3594): (fatty acid synthase) The enzyme encoded by this gene is a multifunctional protein. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA, in the presence of NADPH, into long-chain saturated fatty acids. In some cancer cell lines, this protein has been found to be fused with estrogen receptor-alpha (ER-alpha), in which the N-terminus of FAS is fused in-frame with the C-terminus of ER-alpha. [provided by RefSeq, Jul 2008]
FASN Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FASNNM_004104.5 linkc.5062G>A p.Ala1688Thr missense_variant Exon 29 of 43 ENST00000306749.4 NP_004095.4 P49327
FASNXM_011523538.3 linkc.5062G>A p.Ala1688Thr missense_variant Exon 29 of 43 XP_011521840.1 P49327

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FASNENST00000306749.4 linkc.5062G>A p.Ala1688Thr missense_variant Exon 29 of 43 1 NM_004104.5 ENSP00000304592.2 P49327
FASNENST00000634990.1 linkc.5056G>A p.Ala1686Thr missense_variant Exon 29 of 43 5 ENSP00000488964.1 A0A0U1RQF0

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
152214
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000294
AC:
4
AN:
136154
AF XY:
0.0000271
show subpopulations
Gnomad AFR exome
AF:
0.000284
Gnomad AMR exome
AF:
0.0000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000195
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000144
AC:
20
AN:
1386568
Hom.:
0
Cov.:
42
AF XY:
0.0000161
AC XY:
11
AN XY:
683800
show subpopulations
African (AFR)
AF:
0.000476
AC:
15
AN:
31482
American (AMR)
AF:
0.0000281
AC:
1
AN:
35552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25068
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79088
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39050
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5522
European-Non Finnish (NFE)
AF:
0.00000278
AC:
3
AN:
1077398
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000144
AC:
22
AN:
152332
Hom.:
0
Cov.:
34
AF XY:
0.000201
AC XY:
15
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41576
American (AMR)
AF:
0.000131
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000869
Hom.:
0
Bravo
AF:
0.000121
ESP6500AA
AF:
0.000792
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000628
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 02, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5062G>A (p.A1688T) alteration is located in exon 29 (coding exon 28) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 5062, causing the alanine (A) at amino acid position 1688 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Epileptic encephalopathy Uncertain:1
Sep 01, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1688 of the FASN protein (p.Ala1688Thr). This variant is present in population databases (rs368428251, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 531015). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.21
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.54
D;.
Eigen
Pathogenic
0.96
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.97
D;D
M_CAP
Benign
0.084
D
MetaRNN
Uncertain
0.69
D;D
MetaSVM
Uncertain
-0.18
T
MutationAssessor
Pathogenic
4.4
H;.
PhyloP100
7.6
PrimateAI
Uncertain
0.73
T
PROVEAN
Uncertain
-3.6
D;.
REVEL
Uncertain
0.41
Sift
Uncertain
0.0020
D;.
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.83
MVP
0.61
ClinPred
0.99
D
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.84
gMVP
0.89
Mutation Taster
=18/82
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368428251; hg19: chr17-80041887; API